Study of Genetic Differences in People With Depression

Depressive Disorder, Major Clinical Trial

— Genetics  

Official title:

Study of Genetic Differences in People With Depression

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00229463
• Other study ID #: 01-10-049
• Status: Completed
• Phase: N/A
• First received: September 28, 2005
• Last updated: November 16, 2016
• Start date: January 2002
• Est. completion date: January 2011

Study information

• Verified date: October 2016
• Source: University of California, Los Angeles
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to identify genes involved in depression. Specifically, the investigators will analyze some genes that may be related to whether or not a person responds to antidepressant medication. This project is part of basic scientific research to increase understanding of the role of genetic influences in psychological and mental processes involved in the response to treatment for depression.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: January 2011
• Est. primary completion date: January 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• History of Unipolar Major Depression

• Control subjects must be healthy normal adults

Exclusion Criteria:

• Subjects with mood symptoms that are not severe enough to qualify for MDD

• Subjects with any active medical illness that may be related to ongoing mood disorder

• Normal subjects must be free from: a psychiatric diagnosis, substance abuse, a history of seizure disorder, and any serious medical illness

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Depression
• Depressive Disorder
• Depressive Disorder, Major

Locations

Country	Name	City	State
United States	UCLA Semel Institute for Neuroscience and Human Behavior	Los Angeles	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, Los Angeles

Country where clinical trial is conducted

United States,